Cedric Francois - Net Worth and Insider Trading
Cedric Francois Net Worth
The estimated net worth of Cedric Francois is at least $57 Million dollars as of 2024-10-20. Cedric Francois is the CEO of Apellis Pharmaceuticals Inc and owns about 2,035,230 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $57 Million. Details can be seen in Cedric Francois's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cedric Francois has not made any transactions after 2024-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cedric Francois
Cedric Francois Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cedric Francois owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Cedric Francois’s form 4 insider trades.
Insider Ownership Summary of Cedric Francois
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-03-01 | director & 10 percent owner & Chief Executive Officer |
Cedric Francois Latest Holdings Summary
Cedric Francois currently owns a total of 1 stock. Cedric Francois owns 2,035,230 shares of Apellis Pharmaceuticals Inc (APLS) as of March 1, 2024, with a value of $57 Million.
Latest Holdings of Cedric Francois
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-03-01 | 2,035,230 | 28.00 | 56,986,440 |
Holding Weightings of Cedric Francois
Cedric Francois Form 4 Trading Tracker
According to the SEC Form 4 filings, Cedric Francois has made a total of 26 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 26 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 250,000 shares on March 1, 2024, which brought Cedric Francois around $16 Million.
Insider Trading History of Cedric Francois
- 1
Cedric Francois Trading Performance
Cedric Francois Ownership Network
Cedric Francois Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Cedric Francois is the director & 10 percent owner & Chief Executive Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Cedric Francois made 8 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 463,087. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 308,688 shares made by Pascal Deschatelets , a net sale of 102,839 shares made by Timothy Eugene Sullivan , and a net sale of 8,750 shares made by Alec Machiels .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,280,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,280,451 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Cedric Francois Mailing Address
Above is the net worth, insider trading, and ownership report for Cedric Francois. You might contact Cedric Francois via mailing address: 6400 Westwind Way, Suite A, Crestwood Ky 40014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
